A Personalized, At-Home Breakthrough

One of the most significant treatments for Parkinson’s disease in decades

Addressing Major Unmet Needs in Parkinson's

With large improvements from robust clinical studies

Pivotal Trial to Confirm Sustained Efficacy

Initiating remote trial of Celeste Specialized Phototherapy

Now Recruiting for LightforPd Clinical Trial!

Know someone with Parkinson’s? If your loved one is managing PD, this could be the opportunity they’ve been hoping for.  A new, at-home trial for PD is underway. No travel required.

Check Eligibility

Now Recruiting for LightforPd Clinical Trial!

Know someone with Parkinson’s? If your loved one is managing PD, this could be the opportunity they’ve been hoping for.  A new, at-home trial for PD is underway. No travel required.

Check Eligibility

ADDRESSING MAJOR UNMET NEEDS

A Breakthrough Therapy for People Living with Parkinson’s Disease

Specialized phototherapy addresses both motor and non-motor symptoms

Over 11 million people worldwide live with Parkinson’s disease (PD), a number that is projected to double over the next 20 years. As with so many other neurodegenerative diseases, there have been no major breakthroughs in Parkinson’s disease in decades.

Our personalized at-home device promises to be one of the most significant therapeutic breakthroughs in Parkinson’s disease in decades. We have seen large improvements in our proof-of-concept studies – especially in addressing major unmet needs in Parkinson’s. We are initiating a pivotal trial of our key product, Celeste® specialized phototherapy, to confirm safety and sustained efficacy.

Despite the efficacy of dopaminergic drugs, people with PD continue to experience difficulties with unresolved motor symptoms and non-motor symptoms (e.g., sleep disorders, fatigue, and mood and cognitive problems). Impaired function significantly reduces quality of life for many, often preventing those living with PD from working, exercising, socializing, and doing the things they want to do.

We invite you to join us to improve the lives of individuals suffering from neurodegenerative diseases.

Investor Inquiries

Do you or someone you know suffer with Parkinson’s? Click here for patient information. 

Seeing Specialized Phototherapy Clearly

Our non-invasive specialized phototherapy is well on its way to becoming a physician-prescribed standard of care.
When it comes to motor and non-motor symptoms of Parkinson’s, here’s what we’re seeing so far.

PROMISING RESULTS

Research participants experienced large, clinically meaningful improvements in combined motor and non-motor function
and enjoyed improved quality of life.

NON-INVASIVE

Those who added specialized phototherapy to their existing drug regimen experienced no major device-related side-effects or negative interactions with their current prescriptions.

LIFESTYLE FRIENDLY PROTOCOL

Research participants found our device safe and convenient to use while watching TV, reading, using a smart phone, or other seated activities.
More About Our Clinical Success

Improving Life for People

with Neurodegenerative Diseases

While our first focus is Parkinson’s, we aim to extend our therapeutic platform
to Alzheimer’s and other neurodegenerative diseases,
promising relief and even healing for millions.

Join us in improving lives by supporting our innovation
and participating in our clinical research

Stay Connected

Warren Olanow, MD (1941-2024)

Distinguished physician, researcher, colleague, father, and friend

The entire PhotoPharmics team mourns the passing of Dr. C. Warren Olanow, a pivotal figure in neurology and chairman of our Clinical and Scientific Advisory Board. Dr. Olanow’s groundbreaking work in Parkinson’s and neurodegenerative research has profoundly advanced our understanding and treatment of movement disorders. His legacy will forever inspire our mission. We extend our heartfelt condolences to his family and honor his lifelong dedication to improving patient lives.

The world is less rich without his presence.

Trending Topics

Largest Phototherapy Trial for Parkinson’s Disease

Largest Phototherapy Trial for Parkinson’s Disease

Mar 26, 2024

Pivotal Trial Aims to Improve Overall Function and Quality of Life View on BusinessWire PhotoPharmics, a pioneer in specialized phototherapy for neurodegenerative diseases, alongside the Center for Health + Technology (CHeT) at the University of Rochester Medical...